SCI 115 Week 1 Discussion

SCI 115 Week 1 Discussion

For your primary post, select ONE of the following discussion topics. Write a primary post of at least 125 words that addresses both (a) and (b) for the topic you choose. Also, make a substantive reply to a fellow classmate on any topic. Use your own words. If you use any sources other than the ones specified, you must cite your source.

• (1) Watch the 7.5 minute video by Cox (2016) about how climate change affects "species range". This video can be found in the "Instructor Insights" of Week 1. (a) Describe three things you learned from the video. (b) How does the video relate to the study of biology.

• (2) Sometimes, the results of science have commercial implications.  Based on the articles by Sheft (2008) and/or Weintraub (2016), what do you think would be the role of the business professional in getting ideas from academic research out into the real world? (a) Discuss this in detail and (b) explain how your expertise could contribute.

• (3) The results of science sometimes have commercial implications.  The patent system grants inventors the exclusive right to license or market their invention for a period of 20 years.  Currently, there are patent disputes over a new technique known as "CRISPR-Cas 9".  Based on the article by Ledford (2016), (a) summarize this dispute, and (b) explain why the stakeholders consider this such a big deal.  

References

Cox, J. (2016). Climate change and species range (version 2).

. Retrieved from Instructor Insights, Week 1.

Ledford, H. (2016, September 21).  Titanic clash over CRISPR patents turns ugly.  Nature (News section).  Retrieved from http://www.nature.com/news/titanic-clash-over-crispr-patents-turns-ugly-1.20631

Sheft, J. (2008). Technology transfer and idea commercialization. Nature Biotechnology, 26, 711-712. Retrieved fromhttp://www.nature.com/nbt/journal/v26/n6/full/nbt0608-711.html

Weintraub (2016, February 9). Zika on Wall Street: can these companies really cash in on the virus? Forbes. Retrieved from http://www.forbes.com/sites/arleneweintraub/2016/02/09/zika-on-wall-street-can-these-companies-really-cash-in-on-the-virus/#3417535f7342

http://hwacer.com/Tutorial/sci-115-week-1-discussion/

SCI 115 Week 1 Discussion

For your primary post, select ONE of the following discussion topics. Write a primary post of at least 125 words that addresses both (a) and (b) for the topic you choose. Also, make a substantive reply to a fellow classmate on any topic. Use your own words. If you use any sources other than the ones specified, you must cite your source.

• (1) Watch the 7.5 minute video by Cox (2016) about how climate change affects "species range". This video can be found in the "Instructor Insights" of Week 1. (a) Describe three things you learned from the video. (b) How does the video relate to the study of biology.

• (2) Sometimes, the results of science have commercial implications.  Based on the articles by Sheft (2008) and/or Weintraub (2016), what do you think would be the role of the business professional in getting ideas from academic research out into the real world? (a) Discuss this in detail and (b) explain how your expertise could contribute.

• (3) The results of science sometimes have commercial implications.  The patent system grants inventors the exclusive right to license or market their invention for a period of 20 years.  Currently, there are patent disputes over a new technique known as "CRISPR-Cas 9".  Based on the article by Ledford (2016), (a) summarize this dispute, and (b) explain why the stakeholders consider this such a big deal.  

References

Cox, J. (2016). Climate change and species range (version 2).

. Retrieved from Instructor Insights, Week 1.

Ledford, H. (2016, September 21).  Titanic clash over CRISPR patents turns ugly.  Nature (News section).  Retrieved from http://www.nature.com/news/titanic-clash-over-crispr-patents-turns-ugly-1.20631

Sheft, J. (2008). Technology transfer and idea commercialization. Nature Biotechnology, 26, 711-712. Retrieved fromhttp://www.nature.com/nbt/journal/v26/n6/full/nbt0608-711.html

Weintraub (2016, February 9). Zika on Wall Street: can these companies really cash in on the virus? Forbes. Retrieved from http://www.forbes.com/sites/arleneweintraub/2016/02/09/zika-on-wall-street-can-these-companies-really-cash-in-on-the-virus/#3417535f7342